Department of Medical Genetics, Tohoku University School of Medicine, Seiryo-machi 1-1, Aobaku, Sendai, 980-8574, Japan.
Division of Dynamic Proteome, Institute of Development, Aging, and Cancer, Tohoku University, Seiryo-machi 4-1, Aobaku, Sendai, 980-8575, Japan.
Cell Death Differ. 2020 Mar;27(3):1023-1035. doi: 10.1038/s41418-019-0395-5. Epub 2019 Jul 23.
Leucine zipper-like transcriptional regulator 1 (LZTR1) encodes a member of the BTB-Kelch superfamily, which interacts with the Cullin3 (CUL3)-based E3 ubiquitin ligase complex. Mutations in LZTR1 have been identified in glioblastoma, schwannomatosis, and Noonan syndrome. However, the functional role of LZTR1 in carcinogenesis or human development is not fully understood. Here, we demonstrate that LZTR1 facilitates the polyubiquitination and degradation of RAS via the ubiquitin-proteasome pathway, leading to the inhibition of the RAS/MAPK signaling. The polyubiquitination and degradation of RAS was also observed in cells expressing MRAS, HRAS, NRAS, and KRAS as well as oncogenic RAS mutants and inhibited the activation of ERK1/2 and cell growth. In vivo ubiquitination assays showed that MRAS-K127 and HRAS-K170 were ubiquitinated by LZTR1 and that the polyubiquitinated-chains contained mainly Ub-K48, K63, and K33-linked chains, suggesting its possible involvement in autophagy. Immunoprecipitation analyses showed the interaction of LZTR1 and RAS-GTPases with autophagy-related proteins, including LC3B and SQSTM1/p62. Co-expression of LZTR1 and RAS increased the expression of lipidated form of LC3B. However, long-term treatment with chloroquine had little effect on RAS protein levels, suggesting that the contribution of autophagy to LZTR1-mediated RAS degradation is minimal. Taken together, these results show that LZTR1 functions as a "RAS killer protein" mainly via the ubiquitin-proteasome pathway regardless of the type of RAS GTPase, controlling downstream signal transduction. Our results also suggest a possible association of LZTR1 and RAS-GTPases with the autophagy. These findings provide clues for the elucidation of the mechanisms of RAS degradation and regulation of the RAS/MAPK signaling cascade.
亮氨酸拉链样转录调节因子 1(LZTR1)编码 BTB-Kelch 超家族的成员,与基于 Cullin3(CUL3)的 E3 泛素连接酶复合物相互作用。LZTR1 的突变已在神经胶质瘤、神经鞘瘤病和诺南综合征中被发现。然而,LZTR1 在致癌作用或人类发育中的功能作用尚未完全了解。在这里,我们证明 LZTR1 通过泛素蛋白酶体途径促进 RAS 的多泛素化和降解,从而抑制 RAS/MAPK 信号。在表达 MRAS、HRAS、NRAS 和 KRAS 以及致癌性 RAS 突变体的细胞中也观察到 RAS 的多泛素化和降解,并抑制 ERK1/2 的激活和细胞生长。体内泛素化测定表明,MRAS-K127 和 HRAS-K170 被 LZTR1 泛素化,并且多泛素化链主要包含 Ub-K48、K63 和 K33 连接的链,表明其可能参与自噬。免疫沉淀分析表明 LZTR1 和 RAS-GTPases 与自噬相关蛋白,包括 LC3B 和 SQSTM1/p62 的相互作用。LZTR1 和 RAS 的共表达增加了 LC3B 的脂化形式的表达。然而,长期用氯喹处理对 RAS 蛋白水平几乎没有影响,这表明自噬对 LZTR1 介导的 RAS 降解的贡献最小。总之,这些结果表明 LZTR1 主要通过泛素蛋白酶体途径发挥“RAS 杀手蛋白”的作用,而与 RAS GTPase 的类型无关,控制下游信号转导。我们的结果还表明 LZTR1 和 RAS-GTPases 可能与自噬有关。这些发现为阐明 RAS 降解机制和调节 RAS/MAPK 信号级联提供了线索。